RAC 0.93% $1.62 race oncology ltd

Ann: Appendix 3Y - Dr John Cullity, page-122

  1. 175 Posts.
    lightbulb Created with Sketch. 32
    I agree about the need to get to human clinical data ASAP. Of course there are processes to follow but hopefully this is where we see some time saving from prior approvals.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.